Published Date: 02 Mar 2023
The ONKOTEV score predicts the risk of venous thromboembolism in cancer patients.
Read Full NewsHistorical anatomical illustrations reflect social inequality and may require an ethical context to guide their continued use in clinical education and surgical reference.
New data highlight the activity and safety of MRD-guided preemptive azacitidine in patients with myelodysplastic neoplasms or AML who develop MRD positivity.
Researchers examine overall response rates of a HER3-targeting antibody-drug conjugate in pretreated patients with non-small cell lung cancer.
1.
What Kate Middleton Reminds Us About the Role of Privacy in Healing.
2.
Cancer patients rarely use ancestry testing.
3.
Photoacoustic spectral analysis for gaining knowledge of the tumor microenvironment.
4.
Having a tattoo could increase your risk of developing lymphoma.
5.
Cancer patients with HIV have demonstrated safety with immune checkpoint inhibitors.
1.
Exploring the Mysteries of Myxoma: A New Frontier in Medical Research
2.
Deciphering FFR: A Comprehensive Guide to Understanding Its Meaning
3.
Unlocking the Potential of SCD: A Comprehensive Guide to Diagnosis and Treatment
4.
Revolutionizing Cancer Care: The Promise of Early Detection and Biomarkers
5.
Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
2.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
4.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation